Objective To investigate the expression of polybromo 1(PBRM1)in prostate canc-er tissues and its correlation with CD8+T lymphocyte infiltration.Methods A total of 124 prostate-cancer patients were enrolled as observation group,and 80 patients with benign prostate tumors during the same period were selected as control group.Immunohistochemical staining(IHC),real-time fluo-rescent quantitative polymerase chain reaction(qRT-PCR),and western blot were used to detect the expression of PBRM1 in the tumor tissues of both groups and the adjacent normal tissues of the obser-vation group(more than 1 cm from the tumor edge).Flow cytometry was employed to detect the infil-tration of CD8+and CD4+T lymphocytes in the tissues.Results The positive expression rate of PBRM1 in the tumor tissues of the observation group was 59.68％,which was significantly lower than 85.00％in the control group and 81.45％in the adjacent normal tissues of the observation group(P＜0.001).The relative expression levels of PBRM1 mRNA and PBRM1 protein,as well as the percentage of CD8+T lymphocyte infiltration in the tumor tissues of the observation group were all lower than those in the tumor tissues of the control group and the adjacent normal tissues of the obser-vation group(P＜0.05).Pearson correlation analysis revealed a positive correlation between the rel-ative expression level of PBRM1 protein and the percentage of CD8+T lymphocyte infiltration in the tumor tissues(r=0.856,P＜0.001).In the observation group,patients with tumors having a maxi-mum diameter ≥3 cm,poor differentiation,clinical stage Ⅲ to Ⅳ,Gleason score ≥8,and prostate-specific antigen(PSA)≥20 ng/mL had significantly lower relative expression levels of PBRM1 protein compared to those with tumors having a maximum diameter＜3 cm,moderate to well differentiation,clinical stage Ⅰ to Ⅱ,Gleason score＜8,and PSA＜20 ng/mL,and the differences were statistically sig-nificant(P＜0.05).Conclusion Downregulation of PBRM1 expression in prostate cancer tissues may be associated with an increase in tumor malignancy and a decrease in CD8+T lymphocyte infil-tration,thereby enhancing the tumor's immune escape ability.

Objective:To construct a nomogram model for predicting stress urinary incontinence (SUI) in young and middle-aged women.Methods:Using a sampling survey method, 1 000 questionnaires were distributed to young and middle-aged women in 2 streets of Urumqi community from May 2021 to October 2023 to investigate their basic situation, lifestyle habits and gynecological related information. The International Urinary Incontinence Advisory Committee urinary incontinence questionnaire was used to diagnose SUI, and the patients were divided into SUI group and control group based on the results. Seven hundred and eighty-six questionnaires were collected. The survey results of the two groups were analyzed, and a nomogram model for predicting the occurrence of SUI in young and middle-aged women was constructed and validated.Results:Among the 786 young and middle-aged women, there were 147 cases in the SUI group and 639 cases in the control group. The age, body mass index (BMI), and the incidences of diabetes, chronic constipation, delivery history, macrosomia delivery history, pelvic floor dysfunction in SUI group were significantly higher than those in control group: (44.51 ± 8.20) years vs. (38.60 ± 12.35) years, (27.31 ± 4.53) kg/m 2 vs. (24.28 ± 4.38) kg/m 2, 13.61% (20/147) vs. 3.44% (22/639), 19.05% (28/147) vs. 5.01% (32/639), 90.48% (133/147) vs. 75.90% (485/639), 17.01% (25/147) vs. 3.44% (22/639) and 11.56% (17/147) vs. 3.29% (21/639), and there were statistical differences ( P<0.01). Multivariate Logistic regression analysis result showed that age>44 years, BMI≥30 kg/m 2, diabetes, chronic constipation, delivery history, macrosomia delivery history and pelvic floor dysfunction were independent risk factors for SUI in young and middle-aged women ( RR = 1.511, 2.543, 4.636, 4.293, 2.526, 6.220 and 5.834; 95% CI 1.007 to 2.268, 1.661 to 3.894, 2.281 to 9.422, 2.339 to 7.881, 1.374 to 4.643, 3.205 to 12.071 and 2.641 to 12.888; P<0.05 or <0.01). The age, BMI, diabetes, chronic constipation, delivery history, macrosomia delivery history and pelvic floor dysfunction were used as predictors to construct a nomogram model for predicting the SUI in young and middle-aged women. The 550 cases were randomly selected from the dataset as the training set and the remaining 236 cases as the validation set. The receiver operating characteristic curve was drawn, and the result showed that the area under the training set curve was 0.818 (95% CI 0.773 to 0.862), and the area under the validation set curve was 0.826 (95% CI 0.764 to 0.889); the Hosmer-Lemeshow goodness of fit test in validation set that result showed that the nomogram model had high reliability ( χ2 = 8.48, P>0.05). Conclusions:The incidence of SUI in young and middle-aged women is high. The age >44 years, BMI≥30 kg/m 2, diabetes, chronic constipation, delivery history, macrosomia delivery history and pelvic floor dysfunction are independent risk factors for SUI in young and middle-aged women. The nomogram model based on related risk factors has high predictive value and credibility.